-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QBdow9p456+oTiog7Az7dKTIY9FhrTD5iUYmgczcl+aGbt4JSHZ/o7yJzzazgOdv Tuo9FP/aKsAqo7Lk4F2GQA== 0001259869-04-000001.txt : 20040217 0001259869-04-000001.hdr.sgml : 20040216 20040217175656 ACCESSION NUMBER: 0001259869-04-000001 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040129 FILED AS OF DATE: 20040217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOTECH GROWTH N V CENTRAL INDEX KEY: 0001259869 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50516 FILM NUMBER: 04610792 MAIL ADDRESS: STREET 1: DE RUYTERKADE 62 WILLEMSTAD CITY: CURACO STATE: P8 ZIP: 000000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EYETECH PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001115285 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134104684 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 SEVENTH AVE 18TH FL CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 2129979241 MAIL ADDRESS: STREET 1: 500 SEVENTH AVE 18TH FL CITY: NEW YORK STATE: NY ZIP: 10018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50516 FILM NUMBER: 04610791 BUSINESS ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 3 1 edgar.xml PRIMARY DOCUMENT X0201 3 2004-01-29 0 0001115285 EYETECH PHARMACEUTICALS INC EYET 0001259869 BIOTECH GROWTH N V DE RUYTERKADE 62 WILLEMSTAD CURACAO, NETHERLANDS ANTILLES NETHERLANDS ANTILLES 0 0 1 0 0000924223 BB BIOTECH AG VODERGASSE 3 SCHAFFHAUSEN V8 SWITZERLAND CH-8300 SWITZERLAND 0 0 1 0 Common Stock 45000 D Series C-1 Convertible Preferred Stock Common Stock 1764697 D Series C-2 Convertible Preferred Stock Common Stock 1666665 D Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Eyetech Pharmaceuticals Inc. held directly or indirectly by Biotech Growth N.V. This Form 3 is filed jointly by BB Biotech AG and Biotech Growth N.V. The reporting person disclaims beneficial ownership of common stock except to the extent of any of its or its affiliates' pecuniary interest therein. The Series C-1 Preferred Stock and Series C-2 Preferred Stock converted into Common Stock of the Issuer on a one for one basis. These shares were immediately exercisable. They had no expiration date. Roland Maier, Signatory Authority for Biotech Growth N.V. and BB Biotech AG 2004-02-13 EX-99 3 form3eyetechdec2003.htm FORM 3 JOINT FILER INFORMATION 
Exhibit 99



Form 3 Joint Filer Information



Name: BB Biotech AG(1)



Address: Vodergasse 3

 8300 Schaffhausen CH/Switzerland



Issuer & Ticker Symbol: Eyetech Pharmaceuticals Inc [EYET]



Date of Event Requiring Statement: 1/29/04



Signature:  /s/ Roland Maier

 Signatory Authority for Biotech Growth N.V.

 and BB Biotech AG



(1) Biotech Growth N.V. is a wholly-owned subsidiary of BB

Biotech AG. Accordingly, BB Biotech AG may be deemed to

be the indirect beneficial owner of the securities of

Eyetech Pharmaceuticals Inc held directly or indirectly

by Biotech Growth N.V. This Form 3 is filed jointly

by BB Biotech AG and Biotech Growth N.V.
-----END PRIVACY-ENHANCED MESSAGE-----